CB Scientific (CB Scientific) Change In Receivables : $0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CB Scientific Change In Receivables?

CB Scientific's change in receivables for the quarter that ended in Dec. 2023 was $-0.00 Mil. It means CB Scientific's Accounts Receivable increased by $0.00 Mil from Sep. 2023 to Dec. 2023 .

CB Scientific's change in receivables for the fiscal year that ended in Mar. 2023 was $0.05 Mil. It means CB Scientific's Accounts Receivable declined by $0.05 Mil from Mar. 2022 to Mar. 2023 .

CB Scientific's Accounts Receivable for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CB Scientific's Days Sales Outstanding for the three months ended in Dec. 2023 was 9.78.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CB Scientific's liquidation value for the three months ended in Dec. 2023 was $-0.89 Mil.

CB Scientific Change In Receivables Historical Data

The historical data trend for CB Scientific's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CB Scientific Change In Receivables Chart

CB Scientific Annual Data

Trend

Mar21

Mar22

Mar23

Change In Receivables

-0.06

0.05

CB Scientific Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial							-	-	-	-	-

CB Scientific Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

CB Scientific (OTCPK:CBSC) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CB Scientific's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.003	/	0.028	*	91
=	9.78

2. In Ben Graham's calculation of liquidation value, CB Scientific's accounts receivable are only considered to be worth 75% of book value:

CB Scientific's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.234	-	1.137	+	0.75 * 0.003	+	0.5 * 0.023
=	-0.89

CB Scientific Change In Receivables Related Terms

Thank you for viewing the detailed overview of CB Scientific's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CB Scientific (CB Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CB Scientific Inc (OTCPK:CBSC) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135

Website

https://www.cbscientificinc.com

CB Scientific Inc through its U.S. and international subsidiaries provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.